Pro-melanomagenic role of Interferon-gamma: A paradigm shift
干扰素-γ的促黑色素生成作用:范式转变
基本信息
- 批准号:8716695
- 负责人:
- 金额:$ 19.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-20 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAntibodiesBasic Cancer ResearchBiochemistryBiological AssayBiological MarkersBreast Cancer CellBreedingCTLA4 geneCancer BiologyCancer cell lineCell LineCell TransplantsCell-Mediated CytolysisCellsCollaborationsCutaneous MelanomaDNA DamageDevelopmentDominant-Negative MutationDoseEctopic ExpressionEnsureEnvironmentFacultyFellowshipFluorescenceGene Expression ProfilingGene TargetingGenesGeneticGenotypeGoalsGrowthHepatocyte Growth FactorHumanImageIn VitroIncidenceIndividualInfiltrationInflammatoryInflammatory ResponseInstitutionInterferon Type IIInterferonsKnock-outKnowledgeLaboratoriesLeadLuciferasesMacrophage ActivationMalignant NeoplasmsMediatingMelanoma CellModelingMolecularMolecular BiologyMusNational Cancer InstituteNeonatalOutcomePathway interactionsPatternPeptidesPhosphorylationPlayPopulationPositioning AttributePreventionPrevention strategyReporterResearchResistanceRiskRisk FactorsRoleScientistSignal TransductionSignaling ProteinSkinSkin CancerSmall Interfering RNAStagingSun ExposureT-LymphocyteTestingThe SunTherapeuticTissuesTransgenic MiceTransplantationTumor TissueUV Radiation ExposureUVB inducedUltraviolet B RadiationUltraviolet RaysUrsidae FamilyWomanbasecancer geneticsexperiencegamma-Ain vivoinhibitor/antagonistinsightinterestirradiationmacrophagemalignant breast neoplasmmelanocytemelanomamouse modelnovelpreventprognosticreceptorresearch studyresponsetherapeutic targettumorigenesistumorigenic
项目摘要
DESCRIPTION (provided by applicant): The candidate has a doctorate in Biochemistry and Molecular Biology with extensive experience in using mouse models to perform basic cancer research. During his postdoctoral fellowship, the candidate has generated a novel mouse model that has allowed new insights into how ultraviolet radiation (UV) may cause development of melanoma, the deadliest form of skin cancer. He has made an important discovery that interferon (IFN)-gamma, a signaling protein involved in immunological functions and conventionally thought to be anti-tumorigenesis, may under some circumstances aid the outgrowth and progression of UV- induced melanoma. This high-impact research has formed the basis for the research proposed in this application. The candidate's immediate goal is to elucidate the molecular mechanism(s) of the pro- melanomagenic role of IFN-gamma, and to explore whether inhibition of IFN-gamma could be used as an anti- melanoma therapeutic and/or preventive strategy. In the long-term, the candidate wants to focus on the delineation of the molecular mechanisms of UV-induced melanoma initiation and progression. Environment: The candidate is currently a postdoctoral research fellow in the Laboratory of Cancer Biology and Genetics at the National Cancer Institute, and is seeking an independent research faculty position in an academic or non-profit research institution. He has set up collaborations with a world-class team of scientists with relevant expertise to advise throughout this project, ensuring timely conclusion and high-impact outcome. Research: The candidate has proposed a paradigm-shifting hypothesis that IFN-gamma plays a pro- tumorigenic role in the context of UVB-induced melanomagenesis. The proposed research will elucidate the molecular mechanisms of the pro-melanomagenic effects of IFN-gamma, and will explore whether inhibition of IFN-gamma pathway is a viable treatment and/or preventive strategy for human melanoma. In Specific Aim 1, UV-induced melanomagenesis experiments will be performed in a mouse model of UVB-induced melanomagenesis in the IFN-gamma knockout genetic background to test whether IFN-gamma is required for melanomagenesis. Specific Aim 2 will elucidate the downstream target genes of IFN-gamma signaling that mediate the pro-melanomagenic effects of IFN-gamma, using both human and mouse melanoma cell lines. The applicability of the results will be validated in human melanoma cell lines and tissues. In Specifi Aim 3, novel peptide-based IFN-gamma inhibiting compounds will be validated and tested for their efficacy in preventing UVB-induced melanomagenesis and treating established melanomas in mouse models. It is anticipated that the results obtained from the proposed research will provide significant new translational opportunities for prevention and treatment of human melanoma.
描述(由申请人提供):候选人拥有生物化学和分子生物学博士学位,在使用小鼠模型进行基础癌症研究方面具有丰富的经验。在他的博士后研究期间,这位候选人产生了一种新的小鼠模型,该模型使人们对紫外线辐射(UV)如何导致黑色素瘤(最致命的皮肤癌形式)的发展有了新的认识。他已经做出了一个重要的发现,即干扰素(IFN)-γ,一种参与免疫功能并且通常被认为是抗肿瘤发生的信号蛋白,在某些情况下可能有助于UV诱导的黑素瘤的生长和进展。这项高影响力的研究为本申请中提出的研究奠定了基础。候选人的直接目标是阐明IFN-γ的促黑色素瘤作用的分子机制,并探索IFN-γ的抑制是否可用作抗黑色素瘤治疗和/或预防策略。从长远来看,候选人希望专注于紫外线诱导的黑色素瘤发生和进展的分子机制的描绘。工作环境:候选人目前是国家癌症研究所癌症生物学和遗传学实验室的博士后研究员,正在寻求学术或非营利研究机构的独立研究教师职位。他与世界一流的科学家团队建立了合作关系,他们拥有相关的专业知识,在整个项目中提供建议,确保及时得出结论和产生高影响力的结果。调研:该候选人提出了一个范式转移假说,即IFN-γ在UVB诱导的黑色素瘤发生中起促肿瘤发生作用。拟议的研究将阐明IFN-γ促黑色素瘤作用的分子机制,并将探索抑制IFN-γ通路是否是人类黑色素瘤的可行治疗和/或预防策略。在具体目标1中,将在IFN-γ敲除遗传背景下的UVB诱导的黑色素瘤发生小鼠模型中进行UV诱导的黑色素瘤发生实验,以检测黑色素瘤发生是否需要IFN-γ。具体目标2将使用人和小鼠黑素瘤细胞系阐明介导IFN-γ促黑色素瘤效应的IFN-γ信号传导的下游靶基因。将在人黑色素瘤细胞系和组织中验证结果的适用性。在Specifi Aim 3中,将验证和测试新型基于肽的IFN-γ抑制化合物在预防UVB诱导的黑色素瘤发生和治疗小鼠模型中已建立的黑色素瘤中的功效。预计从拟议研究中获得的结果将为预防和治疗人类黑色素瘤提供重要的新转化机会。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry.
- DOI:10.1016/j.ccr.2014.04.016
- 发表时间:2014-06-16
- 期刊:
- 影响因子:50.3
- 作者:Feng X;Degese MS;Iglesias-Bartolome R;Vaque JP;Molinolo AA;Rodrigues M;Zaidi MR;Ksander BR;Merlino G;Sodhi A;Chen Q;Gutkind JS
- 通讯作者:Gutkind JS
Genetically engineered mouse models of melanoma.
- DOI:10.1002/cncr.30684
- 发表时间:2017-06-01
- 期刊:
- 影响因子:6.2
- 作者:Pérez-Guijarro E;Day CP;Merlino G;Zaidi MR
- 通讯作者:Zaidi MR
From UVs to metastases: modeling melanoma initiation and progression in the mouse.
从 UV 到转移:模拟小鼠黑色素瘤的发生和进展。
- DOI:10.1038/jid.2008.177
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:Zaidi,MRaza;Day,Chi-Ping;Merlino,Glenn
- 通讯作者:Merlino,Glenn
Meeting report from the 10th International Congress of the Society for Melanoma Research, Philadelphia, PA, November 2013.
黑色素瘤研究学会第十届国际大会的会议报告,宾夕法尼亚州费城,2013 年 11 月。
- DOI:10.1111/pcmr.12240
- 发表时间:2014
- 期刊:
- 影响因子:4.3
- 作者:Vultur,Adina;O'Connell,Michael;Webster,Marie;Villanueva,Jessie;Herlyn,Dorothee;Somasundaram,Rajasekharan;Krepler,Clemens;Zaidi,Raza;Patton,Elizabeth;Sekulic,Aleksander;Jonsson,Goran;Weeraratna,AshaniT
- 通讯作者:Weeraratna,AshaniT
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
M. Raza Zaidi其他文献
M. Raza Zaidi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('M. Raza Zaidi', 18)}}的其他基金
CTLA4 as a guardian of the melanocyte stem cell immune privilege: Role in vitilligo
CTLA4 作为黑素细胞干细胞免疫特权的守护者:在白癜风中的作用
- 批准号:
10116287 - 财政年份:2020
- 资助金额:
$ 19.7万 - 项目类别:
Pathobiology of Interferon-gamma in UV radiation-induced melanomagenesis
干扰素-γ在紫外线辐射诱导的黑色素瘤发生中的病理学
- 批准号:
9193631 - 财政年份:2015
- 资助金额:
$ 19.7万 - 项目类别:
Pro-melanomagenic role of Interferon-gamma: A paradigm shift
干扰素-γ的促黑色素生成作用:范式转变
- 批准号:
8548307 - 财政年份:2012
- 资助金额:
$ 19.7万 - 项目类别:
Pro-melanomagenic role of Interferon-gamma: A paradigm shift
干扰素-γ的促黑色素生成作用:范式转变
- 批准号:
8383116 - 财政年份:2012
- 资助金额:
$ 19.7万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 19.7万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 19.7万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 19.7万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 19.7万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 19.7万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 19.7万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 19.7万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 19.7万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 19.7万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 19.7万 - 项目类别: